𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets

✍ Scribed by B Dass; M.M Iravani; M.J Jackson; T.M Engber; A Galdes; P Jenner

Book ID
117490579
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
580 KB
Volume
114
Category
Article
ISSN
0306-4522

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Chronic L-DOPA administration induces dy
Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus)
✍ R. K. B. Pearce; M. Jackson; L. Smith; Prof. P. Jenner; C. D. Marsden πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 934 KB

## Abstract Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L‐DOPA and also occur in several nonhuman primate species after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) and L‐DOPA treatment. The common marmoset (__Callithrix jacchus__) shows pa

An appraisal of the antiparkinsonian act
An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets
✍ Lance Smith; Maria De Salvia; Prof. Peter Jenner; C. David Marsden πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 851 KB

The D2 dopamine agonist piribedil is not widely used in the treatment of Parkinson's disease because it was thought to be effective mainly on parkinsonian tremor and to produce a high incidence of peripheral side effects, particular nausea. In this study, we used 1-methyl-4-phenyl-1,2,3,6-tetrahydro